A new report has shown Missouri is one of the three worst states in the country for passing meaningful legislation to prevent cancer-related suffering and death.
The Food and Drug Administration on Tuesday approved a new capsule-based drug to treat Gaucher's disease.
Biogen Idec says that federal regulators have approved the specialty drugmaker's new treatment for people with relapsing forms of multiple sclerosis.
Consuming in moderation still shown to be important for health
A large international study questions the conventional wisdom that most people should cut back on salt, suggesting that the amount most folks consume is OK for heart health — and too little may be as bad as too much. The findings came under immediate attack by other scientists.
The Ebola outbreak in West Africa is focusing a spotlight on an online tool run by experts in Boston that flagged a "mystery hemorrhagic fever" in forested areas of southeastern Guinea nine days before the World Health Organization formally announced the epidemic.
Patient advocates say some insurance companies are making HIV and AIDS drugs unaffordable in plans issued through the Affordable Care Act by shifting much of the cost to customers.
The use of an experimental drug to treat two Americans diagnosed with Ebola is raising ethical questions about who gets first access to unproven new therapies for the deadly disease. But some health experts fear debate over extremely limited doses will distract from tried-and-true measures to curb the growing outbreak — things like more rapidly identifying and isolating the sick.
A New Mexico physician's assistant who also is a medical marijuana patient says one of the state's largest health care providers violated her rights when it fired her following a positive drug test.
A second American aid worker infected with Ebola arrived Tuesday in Atlanta, where doctors will closely monitor the effect of an experimental drug she agreed to take even though its safety was never tested on humans.
The first Ebola victim to be brought to the United States from Africa was safely escorted into a specialized isolation unit Saturday at one of the nation's best hospitals, where doctors said they are confident the deadly virus won't escape.
Missouri health officials have reported the state’s first case of a mosquito-borne virus that has been spreading to the U.S. from the Caribbean.
Starting July 2015, public college and university students who live on campus will be required to be vaccinated for meningitis, unless they have overriding medical reasons or opposing religious beliefs.
The price is sky-high, but so is demand. A new $1,000-per-pill drug has become the treatment of choice for Americans with hepatitis C, a liver-wasting disease that affects more than 3 million.
An American doctor working with Ebola patients in Liberia has tested positive for the deadly virus, an aid organization said Saturday.
The U.S. Department of Agriculture has issued a public health alert because a Kansas City company refused to recall uninspected chicken products.
The U.S. Food and Drug Administration isn't required to hold public hearings to evaluate the health risks of widespread use of antibiotics in animal feed, a federal appeals court ruled Thursday.
Trader Joe's, Walmart, Costco, Kroger, Ralph's, Shop Rite among affected retailers
As food recalls go, the recent stone-fruit recall from California-based Wawona Packing Company is arguably both better and worse than most: better in that there have been no confirmed reports of people getting sick from contaminated food, worse in that the scope of the recall keeps growing.
The Food and Drug Administration has approved a new combination pain pill from the maker of OxyContin that is designed to discourage abuse by painkiller addicts.
Nutrition facts labels on food packages list ingredients and nutrient levels, but they don't tell consumers outright if a food is good for them.
An experimental drug from the biotech company Genentech failed to slow mental decline in mid-stage studies on more than 500 people with mild to moderate Alzheimer's disease, but showed some promise in the least-impaired participants who received a higher dose.